Singapore opens 1st centre dedicated to stem cell research for Asian heart

CIPHER's approach involves reprogramming blood samples from Asian patients into induced pluripotent stem cells. These cells are then used to create patient-specific heart muscle cell models, which researchers believe offer a more accurate representation of Asian cardiovascular biology than traditional animal models or those based on Western populations, which have historically informed treatment development.

The center's research program builds on a library of over 40 patient-derived disease models from the National Heart Centre Singapore (NHCS), covering conditions such as heart failure, arrhythmogenic disorders, and cardiomyopathy. This methodology allows researchers to observe how a patient's own heart muscle cells behave with their specific disease, providing a platform to test drugs and explore ways to improve heart function and metabolism.

A practical application of these cell platforms is the ability to predict patient responsiveness to drugs without direct administration. This could potentially reduce patient exposure to side effects from ineffective treatments. Singapore's diverse ethnic population, including Chinese, Malays, and Indians, is noted as advantageous for conducting research into varied Asian heart conditions.